Pradžia › Psoriazinis artritas › Džordžija
Psoriazinis artritas klinikiniai tyrimai Džordžija
7 tyrimai dėl Psoriazinis artritas ieško dalyvių vietose Džordžija.
Oficialus tyrimo tekstas (anglų kalba)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
Renkami dalyviai3 fazė
Amžius 3 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Atlanta Research Center for Rheumatology, Marietta
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07321873A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Marietta Rheumatology Associates, Marietta
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Gainesville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- North Georgia Rheumatology Group PC, Lawrenceville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06671496Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Emory Children's Center, Atlanta
- Georgia Regents University Medical Center, Augusta
Renkami dalyviaiStebimasis tyrimas
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-27 · NCT02418442Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Parris and Associates, Lilburn
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2025-10-09 · NCT05669833Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.